{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T10:48:45Z","timestamp":1771670925286,"version":"3.50.1"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["TCRM"],"DOI":"10.2147\/tcrm.s22599","type":"journal-article","created":{"date-parts":[[2012,4,2]],"date-time":"2012-04-02T04:10:10Z","timestamp":1333339810000},"page":"157","source":"Crossref","is-referenced-by-count":11,"title":["Human normal immunoglobulin in the treatment of primary immunodeficiency diseases"],"prefix":"10.2147","author":[{"given":"Philip","family":"Wood","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2012,4]]},"container-title":["Therapeutics and Clinical Risk Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=12434","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T22:12:11Z","timestamp":1477865531000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/human-normal-immunoglobulin-in-the-treatment-of-primary-immunodeficien-peer-reviewed-article-TCRM"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/tcrm.s22599","relation":{},"ISSN":["1178-203X"],"issn-type":[{"value":"1178-203X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}